Bicara Therapeutics Inc. Nonoperating Income (Expense) in USD from Q3 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Bicara Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2023 to Q3 2025.
  • Bicara Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2025 was $4.39M, a 39.4% increase year-over-year.
  • Bicara Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2025 was $19.9M.
  • Bicara Therapeutics Inc. annual Nonoperating Income (Expense) for 2024 was $14.6M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Nonoperating Income (Expense), Annual (USD)

Bicara Therapeutics Inc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $19.9M $4.39M +$1.24M +39.4% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-10
Q2 2025 $18.7M $4.68M +$1.98M +73.3% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $16.7M $5.01M +$2.15M +74.9% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $14.6M $5.87M Oct 1, 2024 Dec 31, 2024 10-K 2025-03-27
Q3 2024 $3.15M +$16.5M Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-10
Q2 2024 $2.7M Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-12
Q1 2024 $2.87M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q3 2023 -$13.3M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12

Bicara Therapeutics Inc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $14.6M +$26.7M Jan 1, 2024 Dec 31, 2024 10-K 2025-03-27
2023 -$12.1M Jan 1, 2023 Dec 31, 2023 10-K 2025-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.